TY - JOUR
T1 - Immunoadjuvant effects of polyadenylic
T2 - Polyuridylic acids through TLR3 and TLR7
AU - Sugiyama, Takahiro
AU - Hoshino, Katsuaki
AU - Saito, Masuyoshi
AU - Yano, Takahiro
AU - Sasaki, Izumi
AU - Yamazaki, Chihiro
AU - Akira, Shizuo
AU - Kaisho, Tsuneyasu
N1 - Funding Information:
JSPS (15790251 to H.K., 18590843 to T.K.); Ministry of Education, Culture, Sports, Science and Technology (MEXT 17047046, 19041070 to T.K.); the Uehara Memorial Foundation, Japan Intractable Diseases Research Foundation; the Mochida Memorial Foundation for Medical and Pharmaceutical Research. RIKEN Junior Research Associate to T.S.
PY - 2008/1
Y1 - 2008/1
N2 - Double-stranded RNA (dsRNA) is produced upon viral infection and can activate innate immunity. Polyinosinic:polycytidylic acids [poly(I:C)] is a synthetic mimetic of dsRNA and functions through an endosomal receptor, Toll-like receptor (TLR) 3 or cytosolic receptors. Another type of dsRNA, polyadenylic:polyuridylic acids [poly(A:U)], can also act as an immune adjuvant, but it remains unclear how it exhibits its adjuvant effects. Here, we have characterized the adjuvant effects of poly(A:U). Poly(A:U) could induce both IFN-α and IL-12p40 from murine bone marrow dendritic cells (DCs). Poly(A:U)-induced IFN-α production depended on a DC subset, plasmacytoid dendritic cell (pDC), and required TLR7. IL-12p40 was also produced by poly(A:U)-stimulated pDC in a TLR7-dependent manner. In addition to pDC, conventional dendritic cell (cDC) also produced IL-12p40 in response to poly(A:U). This IL-12p40 induction resulted from two cDC subsets, CD24high cDC and CD11bhigh cDC in a TLR3- and TLR7-dependent manner, respectively. In vivo injection of poly(A:U) with antigen led to clonal expansion of and IFN-γ production from antigen-specific CD8+ T cells. Consistent with the in vitro findings, TLR3 and TLR7 were required for the clonal T-cell expansion. Notably, TLR3, rather than TLR7, was critical for generating IFN-γ-producing CD8+ T cells. CD8+ T-cell responses induced by poly(A:U) were independent of type I IFN signaling. Our results demonstrate that poly(A:U) functions as an in vivo immunoadjuvant mainly through TLR3 and TLR7.
AB - Double-stranded RNA (dsRNA) is produced upon viral infection and can activate innate immunity. Polyinosinic:polycytidylic acids [poly(I:C)] is a synthetic mimetic of dsRNA and functions through an endosomal receptor, Toll-like receptor (TLR) 3 or cytosolic receptors. Another type of dsRNA, polyadenylic:polyuridylic acids [poly(A:U)], can also act as an immune adjuvant, but it remains unclear how it exhibits its adjuvant effects. Here, we have characterized the adjuvant effects of poly(A:U). Poly(A:U) could induce both IFN-α and IL-12p40 from murine bone marrow dendritic cells (DCs). Poly(A:U)-induced IFN-α production depended on a DC subset, plasmacytoid dendritic cell (pDC), and required TLR7. IL-12p40 was also produced by poly(A:U)-stimulated pDC in a TLR7-dependent manner. In addition to pDC, conventional dendritic cell (cDC) also produced IL-12p40 in response to poly(A:U). This IL-12p40 induction resulted from two cDC subsets, CD24high cDC and CD11bhigh cDC in a TLR3- and TLR7-dependent manner, respectively. In vivo injection of poly(A:U) with antigen led to clonal expansion of and IFN-γ production from antigen-specific CD8+ T cells. Consistent with the in vitro findings, TLR3 and TLR7 were required for the clonal T-cell expansion. Notably, TLR3, rather than TLR7, was critical for generating IFN-γ-producing CD8+ T cells. CD8+ T-cell responses induced by poly(A:U) were independent of type I IFN signaling. Our results demonstrate that poly(A:U) functions as an in vivo immunoadjuvant mainly through TLR3 and TLR7.
KW - Dendritic cell
KW - Double-stranded RNA
KW - Immune adjuvant
KW - Toll-like receptor
UR - http://www.scopus.com/inward/record.url?scp=37549051320&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=37549051320&partnerID=8YFLogxK
U2 - 10.1093/intimm/dxm112
DO - 10.1093/intimm/dxm112
M3 - Article
C2 - 17981792
AN - SCOPUS:37549051320
SN - 0953-8178
VL - 20
SP - 1
EP - 9
JO - International Immunology
JF - International Immunology
IS - 1
ER -